Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study.

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMC 2813728)

Published in Circulation on May 05, 2008

Authors

Hassan A Chami1, Richard B Devereux, John S Gottdiener, Reena Mehra, Mary J Roman, Emelia J Benjamin, Daniel J Gottlieb

Author Affiliations

1: Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA. hchami@bu.edu

Associated clinical trials:

Sleep Heart Health Study (SHHS) Data Coordinating Center (SHHS) | NCT00005275

Articles citing this

Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study. Am J Respir Crit Care Med (2013) 3.09

Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation. Blood (2010) 2.19

Sex-Specific Association of Sleep Apnea Severity With Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community-Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health Study. Circulation (2015) 1.52

Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nat Rev Cardiol (2012) 1.22

The effects of sleep-disordered breathing on arterial stiffness are modulated by age. Sleep (2010) 0.97

EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. J Arrhythm (2016) 0.94

Nasal continuous positive airway pressure improves myocardial perfusion reserve and endothelial-dependent vasodilation in patients with obstructive sleep apnea. J Cardiovasc Magn Reson (2010) 0.94

Treatment of sleep disorders after traumatic brain injury. J Clin Sleep Med (2009) 0.93

The cardiorenal syndrome in heart failure: cardiac? renal? syndrome? Heart Fail Rev (2012) 0.88

Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol (2011) 0.85

Body mass index, gender, and ethnic variations alter the clinical implications of the epworth sleepiness scale in patients with suspected obstructive sleep apnea. Open Respir Med J (2012) 0.84

Impact of untreated obstructive sleep apnea on left and right ventricular myocardial function and effects of CPAP therapy. PLoS One (2013) 0.83

Neurocognitive correlates of nocturnal oxygen desaturation in a memory clinic population. J Clin Exp Neuropsychol (2012) 0.83

Determinants of concentric left ventricular hypertrophy in patients with resistant hypertension: RESIST-POL study. Hypertens Res (2015) 0.81

Development of the National Healthy Sleep Awareness Project Sleep Health Surveillance Questions. J Clin Sleep Med (2015) 0.81

A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease. Vasc Health Risk Manag (2016) 0.80

Arrhythmia risk associated with sleep disordered breathing in chronic heart failure. Curr Heart Fail Rep (2014) 0.80

Obstructive sleep apnea severity is associated with left ventricular mass independent of other cardiovascular risk factors in morbid obesity. J Clin Sleep Med (2013) 0.79

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc (2016) 0.79

Association between Obstructive Sleep Apnea and Left Ventricular Structure by Age and Gender: the Multi-Ethnic Study of Atherosclerosis. Sleep (2016) 0.79

Influence and predicting variables of obstructive sleep apnea on cardiac function and remodeling in patients without congestive heart failure. J Clin Sleep Med (2014) 0.78

Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology. Pulm Circ (2015) 0.78

Clinical implications of sleep disordered breathing in acute myocardial infarction. PLoS One (2014) 0.77

Vascular Dementia. Curr Transl Geriatr Exp Gerontol Rep (2013) 0.77

Sleep-disordered breathing in hypertrophic cardiomyopathy: challenges and opportunities. Chest (2014) 0.76

Echocardiographic Findings in Healthy Elderly People with Unrecognized Sleep Disordered Breathing. J Clin Sleep Med (2015) 0.75

Impact of obstructive sleep apnea and hypertension on left ventricular hypertrophy in Japanese patients. Hypertens Res (2016) 0.75

Effects of Obstructive Sleep Apnea and Obesity on Cardiac Remodeling: The Wisconsin Sleep Cohort Study. Sleep (2016) 0.75

Sleep-Disordered Breathing-Do We Have to Change Gears in Heart Failure? Curr Heart Fail Rep (2016) 0.75

Sleep apnea and the risk of atrial fibrillation recurrence: structural or functional effects? J Am Heart Assoc (2014) 0.75

Sleep-Disordered Breathing and Cardiovascular Correlates in College Football Players. Am J Cardiol (2017) 0.75

Articles cited by this

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32

The Cardiovascular Health Study: design and rationale. Ann Epidemiol (1991) 27.24

Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation (1978) 20.37

An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84

Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med (2000) 18.12

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52

Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med (2001) 12.29

Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA (2000) 12.27

The Sleep Heart Health Study: design, rationale, and methods. Sleep (1997) 7.55

Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest (1995) 6.64

Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol (1992) 6.51

Methods for obtaining and analyzing unattended polysomnography data for a multicenter study. Sleep Heart Health Research Group. Sleep (1998) 4.99

The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol (1990) 4.89

Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest (1997) 3.51

Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med (2005) 3.19

Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med (2002) 3.17

Reliability of scoring respiratory disturbance indices and sleep staging. Sleep (1998) 3.14

Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. J Am Coll Cardiol (1999) 2.98

Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol (1995) 2.74

Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body mass. Hypertension (2006) 2.43

Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. J Am Soc Echocardiogr (1992) 2.31

Short-term variability of respiration and sleep during unattended nonlaboratory polysomnography--the Sleep Heart Health Study. [corrected]. Sleep (2002) 2.20

Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. Circulation (1995) 1.93

Polysomnography performed in the unattended home versus the attended laboratory setting--Sleep Heart Health Study methodology. Sleep (2004) 1.81

Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study. Circulation (1997) 1.66

Left ventricular function in patients with obstructive sleep apnoea syndrome before and after treatment with nasal continuous positive airway pressure. Respiration (2000) 1.59

Possible role of increased blood viscosity in the hemodynamics of systemic hypertension. Am J Cardiol (2000) 1.58

Evaluation of concentric left ventricular geometry in humans: evidence for age-related systematic underestimation. Hypertension (2004) 1.49

Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med (2002) 1.48

Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation (1998) 1.48

Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study. Eur Heart J (2004) 1.37

Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol (2006) 1.28

Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep (1987) 1.16

Impact of obstructive sleep apnea on left ventricular mass and diastolic function. Am J Respir Crit Care Med (2001) 1.16

Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest (1995) 1.10

Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest (2003) 1.05

Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med (1999) 1.03

Blood pressure, cardiac structure and severity of obstructive sleep apnea in a sleep clinic population. J Hypertens (2001) 1.02

Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens (1990) 1.00

Ambulatory blood pressure and left ventricular hypertrophy in subjects with untreated obstructive sleep apnoea and snoring, compared with matched control subjects, and their response to treatment. Clin Sci (Lond) (1994) 0.97

Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: the LIFE Study. Losartan Intervention For Endpoint Reduction in Hypertension Study. J Hypertens (2001) 0.95

Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. J Appl Physiol (1985) (1998) 0.89

Left ventricular structural adaptations to obstructive sleep apnea in dilated cardiomyopathy. Am J Respir Crit Care Med (2006) 0.89

Cross-sectional relations of urinary sodium excretion to cardiac structure and hypertrophy. The Framingham Heart Study. Am J Hypertens (2004) 0.83

Effects of arousal and sleep state on systemic and pulmonary hemodynamics in obstructive apnea. J Appl Physiol (1985) (2000) 0.83

Alterations in the expression of myosin heavy chain isoforms in hypoxia-induced hypertrophied ventricles in rats. Comp Biochem Physiol B Biochem Mol Biol (2003) 0.81

Articles by these authors

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet (2002) 23.18

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care. Ann Intern Med (2003) 21.45

The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care. Ann Intern Med (2003) 18.65

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25

Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60

Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med (2002) 14.26

Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39

Obesity and the risk of heart failure. N Engl J Med (2002) 12.58

Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54

Recommendations for chamber quantification. Eur J Echocardiogr (2006) 11.39

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32

Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA (2007) 10.62

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol (2007) 9.90

Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09

Burden of valvular heart diseases: a population-based study. Lancet (2006) 8.94

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80

Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med (2012) 8.68

Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation (2002) 8.49

Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension (2004) 8.27

Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med (2007) 8.25

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med (2003) 7.86

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27

Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med (2004) 7.12

Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med (2009) 7.06

Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med (2010) 7.03

Creating accountable care organizations: the extended hospital medical staff. Health Aff (Millwood) (2006) 7.02

The revised Ghent nosology for the Marfan syndrome. J Med Genet (2010) 6.87

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet (2002) 6.87

Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation (2003) 6.83

Obesity and the risk of new-onset atrial fibrillation. JAMA (2004) 6.73

Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24

Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation (2004) 6.15

Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13

Aortic stiffness, blood pressure progression, and incident hypertension. JAMA (2012) 6.01

Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med (2002) 5.98

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89

Correlates of long sleep duration. Sleep (2006) 5.67

Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA (2010) 5.37

Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol (2004) 5.26

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26

Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA (2009) 5.22

Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med (2014) 5.11

Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation (2007) 5.10

The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet (2007) 5.02

Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med (2004) 4.92

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87

Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA (2004) 4.85

Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA (2003) 4.77

Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation (2008) 4.69

Incidence and prognosis of syncope. N Engl J Med (2002) 4.69

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation (2011) 4.65

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63

A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med (2008) 4.61

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60

Association between reduced sleep and weight gain in women. Am J Epidemiol (2006) 4.59

Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension (2004) 4.56

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56

Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol (2007) 4.49

Impact of obesity on plasma natriuretic peptide levels. Circulation (2004) 4.46

Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med (2006) 4.36

Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension (2007) 4.20

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16

Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation (2003) 4.09

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation (2005) 4.08

Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97

Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet (2009) 3.81

A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet (2009) 3.78

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med (2003) 3.78

National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation (2005) 3.77

Genome-wide association study of PR interval. Nat Genet (2010) 3.73

Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA (2002) 3.70

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA (2004) 3.68

Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation (2011) 3.68

Aneurysms of the sinuses of Valsalva. Cardiology (2006) 3.64

Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation (2008) 3.56

Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation (2009) 3.55

Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol (2006) 3.48

Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation (2011) 3.48